ribociclib
novartis
['natalee', ' ribo']
natalee adjuvant ribo in early stage hr+ bc median f/u 34.0 months
57% at 2 ys, 20% at 3 yrs
idfs: 90.4% vs 87.1% hr 0.748 p=0.0014
stage 2 hr 0.76, stage 3 hr 0.74
ddfs: 90.8% vs 88.6% hr 0.739 g 3 tox: neutropenia: 43.8% liver aes: 8.3% #asco23 
Chief, Division of Breast Oncology @DanaFarber
Tennis fan
Mother of two teenage girls